ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RVNC Revance Therapeutics Inc

3.79
0.03 (0.80%)
Apr 18 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Revance Therapeutics Inc RVNC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.03 0.80% 3.79 18:58:35
Open Price Low Price High Price Close Price Previous Close
3.75 3.625 3.82 3.79 3.76
more quote information »

Recent News

Date Time Source Heading
4/12/202407:00BWRevance to Present New DAXXIFY® Data at the American Academy..
3/27/202415:05BWRevance Reports Inducement Grants Under Nasdaq Listing Rule..
3/08/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202416:08EDGAR2Form 8-K - Current report
3/05/202416:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
3/04/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202415:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202408:25BWRevance Announces Pricing of $100.0 Million Public Offering..
3/04/202405:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
3/04/202405:37BWRevance Announces Proposed Public Offering of Common Stock
2/29/202415:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/28/202415:07EDGAR2Form 8-K - Current report
2/28/202415:05BWRevance Reports Fourth Quarter and Full Year 2023 Financial..
2/21/202407:01BWRevance to Release Fourth Quarter and Full Year 2023..
2/21/202407:00BWRevance to Participate in Upcoming Investor Conferences
2/14/202414:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202415:28EDGAR2Form 8-K - Current report
2/13/202408:39EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/06/202415:04EDGAR2Form 8-K - Current report
2/02/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202415:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/02/202407:00BWRevance Receives Permanent J-Code for DAXXIFY® and Announces..
2/01/202407:00BWRevance to Participate in the Guggenheim 6th Annual..
1/11/202405:18IHMARKETNEWSWall Street Highlights: Mastercard’s Financial Rise,..
1/08/202407:01EDGAR2Form 8-K - Current report
1/08/202407:00BWRevance Provides Corporate Update, Preliminary Fourth..
1/03/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/03/202415:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/18/202315:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202315:04EDGAR2Form 8-K - Current report
12/12/202304:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
11/14/202315:22EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/08/202315:33EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202315:09EDGAR2Form 8-K - Current report
11/08/202315:06BWRevance Reports Third Quarter 2023 Financial Results,..
11/08/202315:05BWRevance Appoints Erica Jordan as Chief Commercial Officer,..
11/06/202307:00BWRevance to Participate in Upcoming Investor Conferences
11/01/202307:00BWRevance to Release Third Quarter 2023 Financial Results on..
10/26/202307:00BWDAXXIFY® Becomes First Facial Injectable to be Named to..
10/24/202315:05EDGAR2Form SC 13D/A - General statement of acquisition of..
9/19/202308:01EDGAR2Form 8-K - Current report
9/19/202308:00BWRevance Provides Corporate Update at Investor Day
9/07/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202315:21EDGAR2Form 144 - Report of proposed sale of securities
9/05/202316:43EDGAR2Form 144 - Report of proposed sale of securities
9/01/202308:12EDGAR2Form SC 13D - General statement of acquisition of beneficial..

Your Recent History

Delayed Upgrade Clock